miR-429 functions as a tumor suppressor by down-regulating the expression of transcriptional repressor ZEB1 in oral squamous cell carcinoma and breast cancer (Lei et al., 2015[11]; Ye et al., 2015[26]), while suppresses invasion and promotes apoptosis through targeting Bcl-2 and SP1 in esophageal carcinoma (Wang et al., 2013[24]). Here, ZEB1 is linked to neoplasm.